Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia

NCT04638790 is registered in ClinicalTrials.gov with State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia as lead sponsor.

NCT NCT04638790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04638790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia
Lead sponsor
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia
Phase
Phase 3
Overall status
Recruiting
Start date
February 1, 2020
Completion date
December 31, 2026
Enrollment
300 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin lymphoma, adult